Unveiling 5 Analyst Insights On Arcus Biosciences
Unveiling 5 Analyst Insights On Arcus Biosciences
揭示5位分析師對arcus biosciences的看法
Diving into Analyst Ratings: An In-Depth...Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcus Biosciences (NYSE:RCUS) in the last three months.
在過去三個月內，有5位分析師就Arcus Biosciences（紐交所：RCUS）發佈了從看好到看淡的多元觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
Analysts have recently evaluated Arcus Biosciences and provided 12-month price targets. The average target is $26.4, accompanied by a high estimate of $30.00 and a low estimate of $20.00. A decline of 5.71% from the prior average price target is evident in the current average.
分析師最近對arcus biosciences進行了評估，並提供了12個月的價格目標。平均目標爲26.4美元，最高估值爲30.00美元，最低估值爲20.00美元。當前平均目標價格顯示與之前的平均價格目標相比下降了5.71%。
Diving into Analyst Ratings: An In-Depth...
深入探討分析師...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間